A case of Kallmann syndrome
Maria Luisa Cecilia R Arkoncel1, Francis Raymond P Arkoncel, Frances Lina Lantion-Ang
1Department of Medicine, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines. luisa0477@yahoo.com
BMJ Case Reports
|June 16, 2012
Summary
Kallmann syndrome is a rare genetic disorder linking hypogonadotropic hypogonadism and impaired sense of smell. This case highlights a Filipino male with characteristic features and hypoplastic olfactory bulbs, managed with testosterone therapy.
Area of Science:
- Genetics
- Endocrinology
- Neuroscience
Background:
- Kallmann syndrome (KS) is a rare genetic disorder characterized by hypogonadotropic hypogonadism and congenital anosmia or hyposmia.
- It results from abnormal neuronal migration of olfactory axons and gonadotropin-releasing hormone (GnRH)-producing neurons.
Observation:
- A 26-year-old Filipino male presented with eunuchoid habitus, sparse secondary sexual hair, micropenis, and prepubertal testes.
- Associated findings included hyposmia, a high-pitched voice, absent puncta, and a smooth philtrum.
Findings:
- Hormonal assays confirmed hypogonadotropic hypogonadism.
- Brain MRI revealed a hypoplastic left olfactory bulb and an aplastic right olfactory bulb, consistent with KS.
- The patient had a normal male karyotype and no renal abnormalities on ultrasonography.
Implications:
- This case underscores the importance of recognizing the diverse clinical manifestations of Kallmann syndrome.
- Early diagnosis and initiation of androgen replacement therapy are crucial for inducing virilization and managing hypogonadism.
- Further research into the genetic and developmental mechanisms underlying KS can improve diagnostic and therapeutic strategies.
Related Concept Videos
01:17Karyotyping
Overview
01:17Karyotyping
Overview
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...